Sodium Chloride Injection Recalled

B. Braun Medical Inc. announced on Aug. 19, 2026, a voluntary nationwide recall of three lots of 0.9% Sodium Chloride Injection USP, 100mL, in a 150mL PAB^® Container. The recall was prompted by the presence of particulate matter identified as zinc oxide in the solution. Intravenous administration of particulate matter may result in serious adverse health consequences, including pulmonary emboli, blood vessel occlusions that can lead to tissue death and organ damage, phlebitis, immune system activation, organ dysfunction and hemolysis. To date, no serious injuries, deaths or other adverse events related to this issue have been reported. The product is FDA-approved for use in adults and pediatric patients as a source of electrolytes and water for hydration and as a diluent and delivery system for intermittent intravenous administration of compatible drug additives. For more information about the recall, see here.